Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 149 entries
Sorted by: Best Match Show Resources per page
Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Trafalis DT, Chrysogelou E, Dalezis P, Geromichalos G, Kontos M, Andreadis C, Ziras N, Koutsilieris M, Athanassiou AE, Pangalis GA, Papageorgiou A.
PMID: 17335137
J BUON. 2005 Jan-Mar;10(1):89-94.

PURPOSE: A wide variety of human malignancies, including lymphoproliferative neoplasms, express somatistatin (SS) receptors (SS-R). SS induces apoptosis and exerts pronounced antiproliferative effects on various human tumors cell lines, human xenografts, and animal tumors including P388 lymphocytic leukemia. In...

Cite
Trafalis DT, Chrysogelou E, Dalezis P, et al. Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo. J BUON. 2005;10(1):89-94
Trafalis, D. T., Chrysogelou, E., Dalezis, P., Geromichalos, G., Kontos, M., Andreadis, C., Ziras, N., Koutsilieris, M., Athanassiou, A. E., Pangalis, G. A., & Papageorgiou, A. (2005). Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 10(1), 89-94.
Trafalis, D T P, et al. "Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo." Journal of B.U.ON. : official journal of the Balkan Union of Oncology vol. 10,1 (2005): 89-94.
Trafalis DT, Chrysogelou E, Dalezis P, Geromichalos G, Kontos M, Andreadis C, Ziras N, Koutsilieris M, Athanassiou AE, Pangalis GA, Papageorgiou A. Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo. J BUON. 2005 Jan-Mar;10(1):89-94. PMID: 17335137.
Copy Download .nbib Format: NLM
Myofibroblasts in mucoceles and chronic sialadenitis of minor salivary glands.

Hippokratia

Epivatianos A, Iordanidis F, Andreadis D, Markopoulos A, Samara A.
PMID: 24391435
Hippokratia. 2011 Oct;15(4):382-3.

No abstract available.

Cite
Epivatianos A, Iordanidis F, Andreadis D, et al. Myofibroblasts in mucoceles and chronic sialadenitis of minor salivary glands. Hippokratia. 2011;15(4):382-3
Epivatianos, A., Iordanidis, F., Andreadis, D., Markopoulos, A., & Samara, A. (2011). Myofibroblasts in mucoceles and chronic sialadenitis of minor salivary glands. Hippokratia, 15(4), 382-3.
Epivatianos, A, et al. "Myofibroblasts in mucoceles and chronic sialadenitis of minor salivary glands." Hippokratia vol. 15,4 (2011): 382-3.
Epivatianos A, Iordanidis F, Andreadis D, Markopoulos A, Samara A. Myofibroblasts in mucoceles and chronic sialadenitis of minor salivary glands. Hippokratia. 2011 Oct;15(4):382-3. PMID: 24391435; PMCID: PMC3876869.
Copy Download .nbib Format: NLM
Myofibroblasts and transforming growth factor-beta1 in reactive gingival overgrowths.

Journal of oral & maxillofacial research

Epivatianos A, Andreadis D, Iordanidis S.
PMID: 24422026
J Oral Maxillofac Res. 2013 Apr 01;4(1):e3. doi: 10.5037/jomr.2013.4103.

OBJECTIVES: The purpose of this study was to evaluate the oral health-related quality of life of patients treated with implant-supported mandibular overdentures and to compare the attachment systems used.MATERIAL AND METHODS: The presence of myofibroblasts as well as transforming...

Cite
Epivatianos A, Andreadis D, Iordanidis S. Myofibroblasts and transforming growth factor-beta1 in reactive gingival overgrowths. J Oral Maxillofac Res. 2013;4(1):e3doi: 10.5037/jomr.2013.4103.
Epivatianos, A., Andreadis, D., & Iordanidis, S. (2013). Myofibroblasts and transforming growth factor-beta1 in reactive gingival overgrowths. Journal of oral & maxillofacial research, 4(1), e3. https://doi.org/10.5037/jomr.2013.4103
Epivatianos, Apostolos, et al. "Myofibroblasts and transforming growth factor-beta1 in reactive gingival overgrowths." Journal of oral & maxillofacial research vol. 4,1 (2013): e3. doi: https://doi.org/10.5037/jomr.2013.4103
Epivatianos A, Andreadis D, Iordanidis S. Myofibroblasts and transforming growth factor-beta1 in reactive gingival overgrowths. J Oral Maxillofac Res. 2013 Apr 01;4(1):e3. doi: 10.5037/jomr.2013.4103. PMID: 24422026; PMCID: PMC3886107.
Copy Download .nbib Format: NLM
Melatonin attenuates high fat diet-induced fatty liver disease in rats.

World journal of hepatology

Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F.
PMID: 23671720
World J Hepatol. 2013 Apr 27;5(4):160-9. doi: 10.4254/wjh.v5.i4.160.

AIM: To investigate melatonin's preventive action in oxidative stress in a rat model with high fat diet-induced non-alcoholic fatty liver disease (NAFLD).METHODS: NAFLD was induced by high fat diet (HFD) in adult, male, Wistar rats, weighing 180-230 g. After...

Cite
Hatzis G, Ziakas P, Kavantzas N, et al. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol. 2013;5(4):160-9doi: 10.4254/wjh.v5.i4.160.
Hatzis, G., Ziakas, P., Kavantzas, N., Triantafyllou, A., Sigalas, P., Andreadou, I., Ioannidis, K., Chatzis, S., Filis, K., Papalampros, A., & Sigala, F. (2013). Melatonin attenuates high fat diet-induced fatty liver disease in rats. World journal of hepatology, 5(4), 160-9. https://doi.org/10.4254/wjh.v5.i4.160
Hatzis, Gregorios, et al. "Melatonin attenuates high fat diet-induced fatty liver disease in rats." World journal of hepatology vol. 5,4 (2013): 160-9. doi: https://doi.org/10.4254/wjh.v5.i4.160
Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F. Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol. 2013 Apr 27;5(4):160-9. doi: 10.4254/wjh.v5.i4.160. PMID: 23671720; PMCID: PMC3648647.
Copy Download .nbib Format: NLM
Benign gastric outlet obstruction by a large phytobezoar.

Annals of gastroenterology

Andreadis I, Chrisakopoulos G, Papadaki K, Tzias V.
PMID: 24714655
Ann Gastroenterol. 2014;27(1):89-90.

No abstract available.

Cite
Andreadis I, Chrisakopoulos G, Papadaki K, et al. Benign gastric outlet obstruction by a large phytobezoar. Ann Gastroenterol. 2014;27(1):89-90
Andreadis, I., Chrisakopoulos, G., Papadaki, K., & Tzias, V. (2014). Benign gastric outlet obstruction by a large phytobezoar. Annals of gastroenterology, 27(1), 89-90.
Andreadis, Ioannis, et al. "Benign gastric outlet obstruction by a large phytobezoar." Annals of gastroenterology vol. 27,1 (2014): 89-90.
Andreadis I, Chrisakopoulos G, Papadaki K, Tzias V. Benign gastric outlet obstruction by a large phytobezoar. Ann Gastroenterol. 2014;27(1):89-90. PMID: 24714655; PMCID: PMC3959544.
Copy Download .nbib Format: NLM
Surface relaxation of alpha -iron and the embedded-atom method.

Physical review. B, Condensed matter

Andreadis TD, Eridon JM, Haftel MI, Lill JV.
PMID: 9995456
Phys Rev B Condens Matter. 1990 Dec 15;42(18):11540-11552. doi: 10.1103/physrevb.42.11540.

No abstract available.

Cite
Andreadis TD, Eridon JM, Haftel MI, et al. Surface relaxation of alpha -iron and the embedded-atom method. Phys Rev B Condens Matter. 1990;42(18):11540-11552doi: 10.1103/physrevb.42.11540.
Andreadis, T. D., Eridon, J. M., Haftel, M. I., & Lill, J. V. (1990). Surface relaxation of alpha -iron and the embedded-atom method. Physical review. B, Condensed matter, 42(18), 11540-11552. https://doi.org/10.1103/physrevb.42.11540
Andreadis, et al. "Surface relaxation of alpha -iron and the embedded-atom method." Physical review. B, Condensed matter vol. 42,18 (1990): 11540-11552. doi: https://doi.org/10.1103/physrevb.42.11540
Andreadis TD, Eridon JM, Haftel MI, Lill JV. Surface relaxation of alpha -iron and the embedded-atom method. Phys Rev B Condens Matter. 1990 Dec 15;42(18):11540-11552. doi: 10.1103/physrevb.42.11540. PMID: 9995456.
Copy Download .nbib Format: NLM
Antigen delivery format variation and formulation stability through use of a hybrid vector.

Vaccine: X

Beitelshees M, Hill A, Li Y, Chen M, Ahmadi MK, Smith RJ, Andreadis ST, Rostami P, Jones CH, Pfeifer BA.
PMID: 31384734
Vaccine X. 2019 Jan 30;1:100012. doi: 10.1016/j.jvacx.2019.100012. eCollection 2019 Apr 11.

A hybrid biological-biomaterial antigen delivery vector comprised of a polymeric shell encapsulating an

Cite
Beitelshees M, Hill A, Li Y, et al. Antigen delivery format variation and formulation stability through use of a hybrid vector. Vaccine X. 2019;1:100012doi: 10.1016/j.jvacx.2019.100012.
Beitelshees, M., Hill, A., Li, Y., Chen, M., Ahmadi, M. K., Smith, R. J., Andreadis, S. T., Rostami, P., Jones, C. H., & Pfeifer, B. A. (2019). Antigen delivery format variation and formulation stability through use of a hybrid vector. Vaccine: X, 1100012. https://doi.org/10.1016/j.jvacx.2019.100012
Beitelshees, Marie, et al. "Antigen delivery format variation and formulation stability through use of a hybrid vector." Vaccine: X vol. 1 (2019): 100012. doi: https://doi.org/10.1016/j.jvacx.2019.100012
Beitelshees M, Hill A, Li Y, Chen M, Ahmadi MK, Smith RJ, Andreadis ST, Rostami P, Jones CH, Pfeifer BA. Antigen delivery format variation and formulation stability through use of a hybrid vector. Vaccine X. 2019 Jan 30;1:100012. doi: 10.1016/j.jvacx.2019.100012. eCollection 2019 Apr 11. PMID: 31384734; PMCID: PMC6668244.
Copy Download .nbib Format: NLM
Empagliflozin Limits Myocardial Infarction .

Frontiers in physiology

Andreadou I, Efentakis P, Balafas E, Togliatto G, Davos CH, Varela A, Dimitriou CA, Nikolaou PE, Maratou E, Lambadiari V, Ikonomidis I, Kostomitsopoulos N, Brizzi MF, Dimitriadis G, Iliodromitis EK.
PMID: 29311992
Front Physiol. 2017 Dec 19;8:1077. doi: 10.3389/fphys.2017.01077. eCollection 2017.

Empagliflozin (EMPA), a drug approved for type 2 diabetes management, reduced cardiovascular death but is unknown if it reduces myocardial infarction. We sought to investigate: (i) the effect of EMPA on myocardial function and infarct size after ischemia/reperfusion in...

Cite
Andreadou I, Efentakis P, Balafas E, et al. Empagliflozin Limits Myocardial Infarction . Front Physiol. 2017;8:1077doi: 10.3389/fphys.2017.01077.
Andreadou, I., Efentakis, P., Balafas, E., Togliatto, G., Davos, C. H., Varela, A., Dimitriou, C. A., Nikolaou, P. E., Maratou, E., Lambadiari, V., Ikonomidis, I., Kostomitsopoulos, N., Brizzi, M. F., Dimitriadis, G., & Iliodromitis, E. K. (2017). Empagliflozin Limits Myocardial Infarction . Frontiers in physiology, 81077. https://doi.org/10.3389/fphys.2017.01077
Andreadou, Ioanna, et al. "Empagliflozin Limits Myocardial Infarction ." Frontiers in physiology vol. 8 (2017): 1077. doi: https://doi.org/10.3389/fphys.2017.01077
Andreadou I, Efentakis P, Balafas E, Togliatto G, Davos CH, Varela A, Dimitriou CA, Nikolaou PE, Maratou E, Lambadiari V, Ikonomidis I, Kostomitsopoulos N, Brizzi MF, Dimitriadis G, Iliodromitis EK. Empagliflozin Limits Myocardial Infarction . Front Physiol. 2017 Dec 19;8:1077. doi: 10.3389/fphys.2017.01077. eCollection 2017. PMID: 29311992; PMCID: PMC5742117.
Copy Download .nbib Format: NLM
Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein.

Annals of gastroenterology

Deutsch M, Manolakopoulos S, Andreadis I, Giannaris M, Kontos G, Kranidioti H, Pirounaki M, Koskinas J.
PMID: 29333070
Ann Gastroenterol. 2018 Jan-Feb;31(1):77-83. doi: 10.20524/aog.2017.0207. Epub 2017 Oct 26.

BACKGROUND: The diagnosis of bacterial infection in cirrhotic patients may be difficult, because of the absence of classical signs such as fever and raised white blood cell count. The role of C-reactive protein (CRP) in this context has not...

Cite
Deutsch M, Manolakopoulos S, Andreadis I, et al. Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein. Ann Gastroenterol. 2017;31(1):77-83doi: 10.20524/aog.2017.0207.
Deutsch, M., Manolakopoulos, S., Andreadis, I., Giannaris, M., Kontos, G., Kranidioti, H., Pirounaki, M., & Koskinas, J. (2018). Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein. Annals of gastroenterology, 31(1), 77-83. https://doi.org/10.20524/aog.2017.0207
Deutsch, Melanie, et al. "Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein." Annals of gastroenterology vol. 31,1 (2018): 77-83. doi: https://doi.org/10.20524/aog.2017.0207
Deutsch M, Manolakopoulos S, Andreadis I, Giannaris M, Kontos G, Kranidioti H, Pirounaki M, Koskinas J. Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein. Ann Gastroenterol. 2018 Jan-Feb;31(1):77-83. doi: 10.20524/aog.2017.0207. Epub 2017 Oct 26. PMID: 29333070; PMCID: PMC5759615.
Copy Download .nbib Format: NLM
PEGylated Amine-Functionalized Poly(ε-caprolactone) for the Delivery of Plasmid DNA.

Materials (Basel, Switzerland)

Jafari A, Rajabian N, Zhang G, Alaa Mohamed M, Lei P, Andreadis ST, Pfeifer BA, Cheng C.
PMID: 32085401
Materials (Basel). 2020 Feb 18;13(4). doi: 10.3390/ma13040898.

As a promising strategy for the treatment of various diseases, gene therapy has attracted increasing attention over the past decade. Among various gene delivery approaches, non-viral vectors made of synthetic biomaterials have shown significant potential. Due to their synthetic...

Cite
Jafari A, Rajabian N, Zhang G, et al. PEGylated Amine-Functionalized Poly(ε-caprolactone) for the Delivery of Plasmid DNA. Materials (Basel). 2020;13(4)doi: 10.3390/ma13040898.
Jafari, A., Rajabian, N., Zhang, G., Alaa Mohamed, M., Lei, P., Andreadis, S. T., Pfeifer, B. A., & Cheng, C. (2020). PEGylated Amine-Functionalized Poly(ε-caprolactone) for the Delivery of Plasmid DNA. Materials (Basel, Switzerland), 13(4), . https://doi.org/10.3390/ma13040898
Jafari, Amin, et al. "PEGylated Amine-Functionalized Poly(ε-caprolactone) for the Delivery of Plasmid DNA." Materials (Basel, Switzerland) vol. 13,4 (2020). doi: https://doi.org/10.3390/ma13040898
Jafari A, Rajabian N, Zhang G, Alaa Mohamed M, Lei P, Andreadis ST, Pfeifer BA, Cheng C. PEGylated Amine-Functionalized Poly(ε-caprolactone) for the Delivery of Plasmid DNA. Materials (Basel). 2020 Feb 18;13(4). doi: 10.3390/ma13040898. PMID: 32085401; PMCID: PMC7079624.
Copy Download .nbib Format: NLM
Editorial: PCSK9: Importance in Physiology and Pathophysiology.

Frontiers in physiology

Schulz R, Andreadou I, Ferdinandy P.
PMID: 34381377
Front Physiol. 2021 Jul 26;12:706115. doi: 10.3389/fphys.2021.706115. eCollection 2021.

No abstract available.

Cite
Schulz R, Andreadou I, Ferdinandy P. Editorial: PCSK9: Importance in Physiology and Pathophysiology. Front Physiol. 2021;12:706115doi: 10.3389/fphys.2021.706115.
Schulz, R., Andreadou, I., & Ferdinandy, P. (2021). Editorial: PCSK9: Importance in Physiology and Pathophysiology. Frontiers in physiology, 12706115. https://doi.org/10.3389/fphys.2021.706115
Schulz, Rainer, et al. "Editorial: PCSK9: Importance in Physiology and Pathophysiology." Frontiers in physiology vol. 12 (2021): 706115. doi: https://doi.org/10.3389/fphys.2021.706115
Schulz R, Andreadou I, Ferdinandy P. Editorial: PCSK9: Importance in Physiology and Pathophysiology. Front Physiol. 2021 Jul 26;12:706115. doi: 10.3389/fphys.2021.706115. eCollection 2021. PMID: 34381377; PMCID: PMC8350389.
Copy Download .nbib Format: NLM
Molecular immuno-imaging improves tumor detection in head and neck cancer.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Li JH, Forghani R, Bure L, Wojtkiewicz GR, Wu Y, Iwamoto Y, Ali M, Li A, Wang C, Jalali Motlagh N, Papadakis AI, Pusztaszeri MP, Spatz A, Curtin H, Cheng YS, Chen JW.
PMID: 34919761
FASEB J. 2022 Jan;36(1):e22092. doi: 10.1096/fj.202100864R.

Detection and accurate delineation of tumor is important for the management of head and neck squamous cell carcinoma (HNSCC) but is challenging with current imaging techniques. In this study, we evaluated whether molecular immuno-imaging targeting myeloperoxidase (MPO) activity, an...

Cite
Li JH, Forghani R, Bure L, et al. Molecular immuno-imaging improves tumor detection in head and neck cancer. FASEB J. 2022;36(1):e22092doi: 10.1096/fj.202100864R.
Li, J. H., Forghani, R., Bure, L., Wojtkiewicz, G. R., Wu, Y., Iwamoto, Y., Ali, M., Li, A., Wang, C., Jalali Motlagh, N., Papadakis, A. I., Pusztaszeri, M. P., Spatz, A., Curtin, H., Cheng, Y. S., & Chen, J. W. (2022). Molecular immuno-imaging improves tumor detection in head and neck cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36(1), e22092. https://doi.org/10.1096/fj.202100864R
Li, Jing-Hui, et al. "Molecular immuno-imaging improves tumor detection in head and neck cancer." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. 36,1 (2022): e22092. doi: https://doi.org/10.1096/fj.202100864R
Li JH, Forghani R, Bure L, Wojtkiewicz GR, Wu Y, Iwamoto Y, Ali M, Li A, Wang C, Jalali Motlagh N, Papadakis AI, Pusztaszeri MP, Spatz A, Curtin H, Cheng YS, Chen JW. Molecular immuno-imaging improves tumor detection in head and neck cancer. FASEB J. 2022 Jan;36(1):e22092. doi: 10.1096/fj.202100864R. PMID: 34919761.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 149 entries